Negative regulation of SMAD protein signal transduction

pathway activity — cross-omics
GO:0060392Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of SMAD protein signal transduction pathway is significantly associated with the RNA expression of multiple genes, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CDC25A, DCN, and C1QTNF7, each associated with the pathway in up to 6 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of SMAD protein signal transduction activity versus CDC25A in LSCC (Pearson r = -0.13).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCCDC25A →-0.825-0.572<.001<.00136
OVDCN →+1.492+0.211<.001<.00135
OVC1QTNF7 →+0.794+0.156.003.00526
OVLMOD1 →+1.055+0.198<.001<.00135
OVLHFPL6 →+0.896+0.171.002.00335
LSCCZEB1 →+0.406+0.519.005.00235
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0060392 vs CDC25A — LSCC

Per-sample scatter of Negative regulation of SMAD protein signal transduction activity vs CDC25A in LSCC.

Explore this scatter interactively →

Exploration